Abstract:Kinase drug selectivity is the ground challenge in cancer research. Due to the structurally similar kinase drug pockets, off-target inhibitor toxicity has been a major cause for clinical trial failures. The pockets are similar but not identical. Here, we describe a transformation invariant protocol to identify distinct geometric features in the drug pocket that can distinguish one kinase from all others. We integrate available experimental structures with the artificial intelligence-based structural kinome, performing a kinome-wide structural bioinformatic analysis to establish the structural principles of kinase drug selectivity. We generate the structural landscape from the experimental kinase-ligand complexes and propose a binary network that encapsulates the information. The results show that all kinases contain binary units that are shared by less than seven other kinases in the kinome. 331 kinases contain unique binary units that may distinguish them from all others. The structural features encoded by these binary units in the network represent the inhibitor-accessible geometric space that may capture the kinome-wide selectivity. Our proposed binary network with the unsupervised clustering can serve as a general structural bioinformatic protocol for extracting the distinguishing structural features for any protein from their families. We apply the binary network to epidermal growth factor receptor tyrosine kinase inhibitor selectivity by targeting the gate area and the AKT1 serine/threonine kinase selectivity by binding to the αC-helix region and the allosteric pocket. Finally, we develop the cross-platform software, KDS (Kinase Drug Selectivity), for customized visualization and analysis of the binary networks in the human kinome (https://github.com/CBIIT/KDS).

Exploring Kinase Inhibitors Binding Mode with Docking Method

A Multi-Target Docking System of Human Kinome

Comprehensive Assessment of Nine Docking Programs on Type II Kinase Inhibitors: Prediction Accuracy of Sampling Power, Scoring Power and Screening Power.

Rapid Identification of Inhibitors and Prediction of Ligand Selectivity for Multiple Proteins: Application to Protein Kinases

Investigation of Crystal Structures in Structure-Based Virtual Screening for Protein Kinase Inhibitors.

Docking of Protein Kinase B Inhibitors: Implications in the Structure-Based Optimization of A Novel Scaffold

Feasibility of using molecular docking-based virtual screening for searching dual target kinase inhibitors

Action Mechanisms and Structure–activity Relationships of PI3Kγ Inhibitors on the Enzyme: a Molecular Modeling Study

Exploring drug repositioning possibilities of kinase inhibitors via molecular simulation

Docking Challenge: Protein Sampling and Molecular Docking Performance

[The Feasibility of Application of Reverse Docking Method to the Selectivity Studies of Protein Kinase Inhibitors].

Assessing an Ensemble Docking-Based Virtual Screening Strategy for Kinase Targets by Considering Protein Flexibility

Revealing the Unbinding Kinetics and Mechanism of Type I and Type II Protein Kinase Inhibitors by Local-Scaled Molecular Dynamics Simulations

Using the Structural Kinome to Systematize Kinase Drug Discovery

Using 3D-QSAR and Molecular Docking Insight into Inhibitors Binding with Complex-Associated Kinases CDK8

Pharmacophore Modeling and in Silico Screening Studies to Design Potential KDR Kinase Inhibitors

Docking-informed machine learning for kinome wide affinity prediction

Discovery of Novel Pim-1 Kinase Inhibitors with a Flexible-Receptor Docking Protocol

Integrating Docking Scores, Interaction Profiles and Molecular Descriptors to Improve the Accuracy of Molecular Docking: Toward the Discovery of Novel Akt1 Inhibitors

Strategy toward Kinase-Selective Drug Discovery

Exploration of Type II Binding Mode: A Privileged Approach for Kinase Inhibitor Focused Drug Discovery?